Single-cell multiomic profiling of individuals at risk for rheumatoid arthritis identified an expanded population of activated, senescent-like naive B cells that precedes clinical disease onset. These cells produce polyreactive and autoreactive antibodies and present self-antigens to T cells, linking immune cell aging to the transition from preclinical autoimmunity to overt arthritis. The finding positions cellular senescence within the adaptive immune compartment as a measurable driver of autoimmune progression rather than a bystander of chronic inflammation.
Key Points
- Senescent-like naive B cells expand before clinical rheumatoid arthritis appears
- These cells carry polyreactive and autoreactive antibody repertoires
- They present self-antigens to T cells, amplifying autoimmune activation
Longevity Analysis
Senescence is typically framed as a tissue-level phenomenon, yet here it appears in the cells responsible for distinguishing self from non-self — a failure mode that converts routine immune surveillance into sustained self-directed attack. For anyone tracking autoimmune risk, this shifts the window of useful intervention years earlier, into a period when circulating cell states can be measured while joints remain intact. It also reframes senolytic and inflammation-lowering strategies as potentially relevant to the body's defense architecture, not only to the structural tissues that bear the eventual damage.
Original published by Nature Aging, by Xiaohao Wu.